{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:30:38Z","timestamp":1790742638378,"version":"4.1.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.mcna.2019.08.005","type":"journal-article","created":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T16:11:18Z","timestamp":1574179878000},"page":"1-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Approach to Patients with Eosinophilia"],"prefix":"10.1016","volume":"104","author":[{"given":"Fei Li","family":"Kuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.mcna.2019.08.005_bib1","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1136\/thx.41.7.503","article-title":"Charcot-Leyden crystals and Curschmann spirals in asthmatic sputum","volume":"41","author":"Sakula","year":"1986","journal-title":"Thorax"},{"key":"10.1016\/j.mcna.2019.08.005_bib2","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3389\/fimmu.2014.00570","article-title":"Eosinophil cytokines, chemokines, and growth factors: emerging roles in immunity","volume":"5","author":"Davoine","year":"2014","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.mcna.2019.08.005_bib3","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1189\/jlb.3RU0214-110R","article-title":"Unraveling the complexity of lipid body organelles in human eosinophils","volume":"96","author":"Melo","year":"2014","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.mcna.2019.08.005_bib4","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3389\/fimmu.2014.00496","article-title":"Eosinophil secretion of granule-derived cytokines","volume":"5","author":"Spencer","year":"2014","journal-title":"Front Immunol"},{"issue":"20","key":"10.1016\/j.mcna.2019.08.005_bib5","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1182\/blood-2018-04-842260","article-title":"Charcot-Leyden crystal formation is closely associated with eosinophil extracellular trap cell death","volume":"132","author":"Ueki","year":"2018","journal-title":"Blood"},{"issue":"5 Pt 1","key":"10.1016\/j.mcna.2019.08.005_bib6","doi-asserted-by":"crossref","first-page":"909","DOI":"10.4269\/ajtmh.1977.26.909","article-title":"Immune responses during human schistosomiasis mansoni. II. Occurrence of eosinophil-dependent cytotoxic antibodies in relation to intensity and duration of infection","volume":"26","author":"Sher","year":"1977","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.mcna.2019.08.005_bib7","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.4049\/jimmunol.126.3.1025","article-title":"Studies of the antibody-dependent killing of schistosomula of Schistosoma mansoni employing haptenic target antigens. II. In\u00a0vitro killing of TNP-schistosomula by human eosinophils and neutrophils","volume":"126","author":"Moser","year":"1981","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.mcna.2019.08.005_bib8","series-title":"Eosinophils in health and disease","year":"2012"},{"issue":"12","key":"10.1016\/j.mcna.2019.08.005_bib9","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/nri.2017.95","article-title":"Functions of tissue-resident eosinophils","volume":"17","author":"Weller","year":"2017","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"10.1016\/j.mcna.2019.08.005_bib10","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1515\/cclm-2016-0716","article-title":"Within-day biological variation and hour-to-hour reference change values for hematological parameters","volume":"55","author":"Hilderink","year":"2017","journal-title":"Clin Chem Lab Med"},{"issue":"7","key":"10.1016\/j.mcna.2019.08.005_bib11","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3109\/00365513.2011.602422","article-title":"Diurnal variation of hematology parameters in healthy young males: the Bispebjerg study of diurnal variations","volume":"71","author":"Sennels","year":"2011","journal-title":"Scand J Clin Lab Invest"},{"issue":"4","key":"10.1016\/j.mcna.2019.08.005_bib12","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.jaci.2013.06.037","article-title":"Marked and persistent eosinophilia in the absence of clinical manifestations","volume":"133","author":"Chen","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.mcna.2019.08.005_bib13","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1053\/j.gastro.2007.08.017","article-title":"Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment","volume":"133","author":"Furuta","year":"2007","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.mcna.2019.08.005_bib14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jaci.2011.02.040","article-title":"Eosinophilic esophagitis: updated consensus recommendations for children and adults","volume":"128","author":"Liacouras","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.mcna.2019.08.005_bib15","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1136\/gutjnl-2015-310991","article-title":"Proton pump inhibitor-responsive oesophageal eosinophilia: an entity challenging current diagnostic criteria for eosinophilic oesophagitis","volume":"65","author":"Molina-Infante","year":"2016","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.mcna.2019.08.005_bib16","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1053\/j.gastro.2018.07.009","article-title":"Updated international consensus diagnostic criteria for eosinophilic esophagitis: proceedings of the AGREE conference","volume":"155","author":"Dellon","year":"2018","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.mcna.2019.08.005_bib17","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2350\/11-05-0130.1","article-title":"Quantity and distribution of eosinophils in the gastrointestinal tract of children","volume":"9","author":"DeBrosse","year":"2006","journal-title":"Pediatr Dev Pathol"},{"issue":"4","key":"10.1016\/j.mcna.2019.08.005_bib18","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/modpathol.2010.221","article-title":"Eosinophilic gastritis: histopathological characterization and quantification of the normal gastric eosinophil content","volume":"24","author":"Lwin","year":"2011","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.mcna.2019.08.005_bib19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/JLB.5MR0118-028R","article-title":"Revisiting the NIH taskforce on the research needs of eosinophil-associated diseases (RE-TREAD)","volume":"104","author":"Khoury","year":"2018","journal-title":"J\u00a0Leukoc Biol"},{"issue":"3","key":"10.1016\/j.mcna.2019.08.005_bib20","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.iac.2015.05.003","article-title":"Eosinophilia in infectious diseases","volume":"35","author":"O\u2019Connell","year":"2015","journal-title":"Immunol Allergy Clin North Am"},{"issue":"3","key":"10.1016\/j.mcna.2019.08.005_bib21","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s11904-015-0272-x","article-title":"Eosinophilia in patients infected with human immunodeficiency virus","volume":"12","author":"Chou","year":"2015","journal-title":"Curr Hiv\/AIDS Rep"},{"issue":"9","key":"10.1016\/j.mcna.2019.08.005_bib22","doi-asserted-by":"crossref","first-page":"554","DOI":"10.14423\/SMJ.0000000000000159","article-title":"Eosinophilia and associated factors in a large cohort of patients infected with human immunodeficiency virus","volume":"107","author":"Al Mohajer","year":"2014","journal-title":"South Med J"},{"issue":"1","key":"10.1016\/j.mcna.2019.08.005_bib23","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1001\/archinte.1983.00350010194044","article-title":"Late generalized tuberculosis and eosinophilia","volume":"143","author":"Flores","year":"1983","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.mcna.2019.08.005_bib24","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1378\/chest.101.6.1708","article-title":"Pulmonary eosinophilia in pulmonary tuberculosis","volume":"101","author":"Vijayan","year":"1992","journal-title":"Chest"},{"issue":"14","key":"10.1016\/j.mcna.2019.08.005_bib25","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1182\/blood-2008-07-166595","article-title":"TLR2-dependent eosinophil interactions with mycobacteria: role of alpha-defensins","volume":"113","author":"Driss","year":"2009","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.mcna.2019.08.005_bib26","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12931-017-0579-9","article-title":"An association between pulmonary Mycobacterium avium-intracellulare complex infections and biomarkers of Th2-type inflammation","volume":"18","author":"Pfeffer","year":"2017","journal-title":"Respir Res"},{"issue":"8","key":"10.1016\/j.mcna.2019.08.005_bib27","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/cid\/cix016","article-title":"Posttreatment reactions after single-dose diethylcarbamazine or ivermectin in subjects with loa loa infection","volume":"64","author":"Herrick","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mcna.2019.08.005_bib28","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3389\/fimmu.2018.00207","article-title":"Elevated systemic levels of eosinophil, neutrophil, and mast cell granular proteins in strongyloides stercoralis infection that diminish following treatment","volume":"9","author":"Rajamanickam","year":"2018","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.mcna.2019.08.005_bib29","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/infdis\/154.1.10","article-title":"Loa loa infection in temporary residents of endemic regions: recognition of a hyperresponsive syndrome with characteristic clinical manifestations","volume":"154","author":"Nutman","year":"1986","journal-title":"J\u00a0Infect Dis"},{"issue":"3","key":"10.1016\/j.mcna.2019.08.005_bib30","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.amjcard.2013.03.053","article-title":"Eosinophilic endocarditis and Strongyloides stercoralis","volume":"112","author":"Thaden","year":"2013","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.mcna.2019.08.005_bib31","first-page":"511","article-title":"Inpatient adverse cutaneous drug eruptions and eosinophilia","volume":"137","author":"Romagosa","year":"2001","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.mcna.2019.08.005_bib32","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s12016-015-8491-x","article-title":"Eosinophilic drug allergy","volume":"50","author":"Kuruvilla","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"issue":"2","key":"10.1016\/j.mcna.2019.08.005_bib33","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/bcp.13096","article-title":"Eosinophilic drug reactions detected by a prospective pharmacovigilance programme in a tertiary hospital","volume":"83","author":"Ram\u00edrez","year":"2017","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.mcna.2019.08.005_bib34","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/bjd.12948","article-title":"Elevated serum thymus and activation-regulated chemokine (TARC\/CCL17) relates to reactivation of human herpesvirus 6 in drug reaction with eosinophilia and systemic symptoms (DRESS)\/drug-induced hypersensitivity syndrome (DIHS)","volume":"171","author":"Ogawa","year":"2014","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.mcna.2019.08.005_bib35","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/1346-8138.14776","article-title":"Drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms due to lamotrigine differs from that due to other drugs","volume":"46","author":"Tashiro","year":"2019","journal-title":"J\u00a0Dermatol"},{"issue":"3","key":"10.1016\/j.mcna.2019.08.005_bib36","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2133.2006.07704.x","article-title":"Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?","volume":"156","author":"Kardaun","year":"2007","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.mcna.2019.08.005_bib37","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/bjd.12501","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study","volume":"169","author":"Kardaun","year":"2013","journal-title":"Br J Dermatol"},{"issue":"12","key":"10.1016\/j.mcna.2019.08.005_bib38","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1001\/archdermatol.2010.198","article-title":"Drug reaction with eosinophilia and systemic symptoms: a retrospective study of 60 cases","volume":"146","author":"Chen","year":"2010","journal-title":"Arch Dermatol"},{"issue":"7","key":"10.1016\/j.mcna.2019.08.005_bib39","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.amjmed.2011.01.017","article-title":"The DRESS syndrome: a literature review","volume":"124","author":"Cacoub","year":"2011","journal-title":"Am J Med"},{"issue":"22","key":"10.1016\/j.mcna.2019.08.005_bib40","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1001\/jama.1989.03430220033006","article-title":"Eosinophilia-myalgia syndrome\u2014New Mexico","volume":"262","year":"1989","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.mcna.2019.08.005_bib41","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jaci.2007.03.015","article-title":"Eosinophilia in systemic mastocytosis: clinical and molecular correlates and prognostic significance","volume":"120","author":"B\u00f6hm","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.mcna.2019.08.005_bib42","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jaci.2007.05.024","article-title":"KIT D816V-associated systemic mastocytosis with eosinophilia and FIP1L1\/PDGFRA-associated chronic eosinophilic leukemia are distinct entities","volume":"120","author":"Maric","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.mcna.2019.08.005_bib43","first-page":"113","article-title":"Eosinophilia after allogeneic bone marrow transplantation using the busulfan and cyclophosphamide preparative regimen","volume":"14","author":"Kalaycioglu","year":"1994","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.mcna.2019.08.005_bib44","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/petr.12693","article-title":"Eosinophilic density in graft biopsies positive for rejection and blood eosinophil count can predict development of post-transplant digestive tract eosinophilia","volume":"20","author":"Bush","year":"2016","journal-title":"Pediatr Transplant"},{"issue":"20","key":"10.1016\/j.mcna.2019.08.005_bib45","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1056\/NEJMoa1702079","article-title":"Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis","volume":"376","author":"Wechsler","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.mcna.2019.08.005_bib46","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.iac.2015.05.004","article-title":"Eosinophilia associated with disorders of immune deficiency or immune dysregulation","volume":"35","author":"Williams","year":"2015","journal-title":"Immunol Allergy Clin North Am"},{"issue":"2","key":"10.1016\/j.mcna.2019.08.005_bib47","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1073\/pnas.0610289104","article-title":"Lymphopenic mice reconstituted with limited repertoire T\u00a0cells develop severe, multiorgan, Th2-associated inflammatory disease","volume":"104","author":"Milner","year":"2007","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"3","key":"10.1016\/j.mcna.2019.08.005_bib48","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.jaci.2012.12.664","article-title":"Empiric 6-food elimination diet induced and maintained prolonged remission in patients with adult eosinophilic esophagitis: a prospective study on the food cause of the disease","volume":"131","author":"Lucendo","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.mcna.2019.08.005_bib49","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.jaci.2017.08.038","article-title":"Step-up empiric elimination diet for pediatric and adult eosinophilic esophagitis: the 2-4-6 study","volume":"141","author":"Molina-Infante","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.mcna.2019.08.005_bib50","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.cgh.2006.05.026","article-title":"Effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis","volume":"4","author":"Kagalwalla","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"26","key":"10.1016\/j.mcna.2019.08.005_bib51","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","article-title":"Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma","volume":"378","author":"Castro","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.mcna.2019.08.005_bib52","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jaci.2012.02.019","article-title":"Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes","volume":"130","author":"Valent","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.mcna.2019.08.005_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-197501000-00001","article-title":"The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature","volume":"54","author":"Chusid","year":"1975","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"10.1016\/j.mcna.2019.08.005_bib54","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1111\/all.13146","article-title":"Dysregulation of interleukin 5 expression in familial eosinophilia","volume":"72","author":"Prakash Babu","year":"2017","journal-title":"Allergy"},{"issue":"11","key":"10.1016\/j.mcna.2019.08.005_bib55","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1182\/blood-2003-11-3850","article-title":"Familial eosinophilia: a benign disorder?","volume":"103","author":"Klion","year":"2004","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.mcna.2019.08.005_bib56","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1182\/blood-2014-11-551614","article-title":"How I treat hypereosinophilic syndromes","volume":"126","author":"Klion","year":"2015","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.mcna.2019.08.005_bib57","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/j.jaip.2018.04.033","article-title":"Long-term clinical outcomes of high-dose mepolizumab treatment for hypereosinophilic syndrome","volume":"6","author":"Kuang","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.mcna.2019.08.005_bib58","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.jaci.2009.09.022","article-title":"Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy","volume":"124","author":"Ogbogu","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.mcna.2019.08.005_bib59","doi-asserted-by":"crossref","first-page":"AB277","DOI":"10.1016\/j.jaci.2017.12.883","article-title":"Myeloproliferative hypereosinophilic syndrome: retrospective analysis of cytogenetic and molecular features","volume":"141","author":"Pongdee","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"14","key":"10.1016\/j.mcna.2019.08.005_bib60","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1056\/NEJMoa1812185","article-title":"Benralizumab for PDGFRA-negative hypereosinophilic syndrome","volume":"380","author":"Kuang","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.mcna.2019.08.005_bib61","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jaip.2015.01.013","article-title":"Biologic therapies targeting eosinophils: current status and future prospects","volume":"3","author":"Legrand","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.mcna.2019.08.005_bib62","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1182\/blood-2018-02-835330","article-title":"Dexpramipexole as an oral steroid-sparing agent in hypereosinophilic syndromes","volume":"132","author":"Panch","year":"2018","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.mcna.2019.08.005_bib63","doi-asserted-by":"crossref","first-page":"E61","DOI":"10.1002\/lary.27564","article-title":"Dexpramipexole depletes blood and tissue eosinophils in nasal polyps with no change in polyp size","volume":"129","author":"Laidlaw","year":"2019","journal-title":"Laryngoscope"},{"issue":"2","key":"10.1016\/j.mcna.2019.08.005_bib64","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jaci.2012.07.055","article-title":"Long-term safety of mepolizumab for the treatment of hypereosinophilic syndromes","volume":"131","author":"Roufosse","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.mcna.2019.08.005_bib65","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1365-2222.2010.03484.x","article-title":"Eosinophils in health and disease: the LIAR hypothesis","volume":"40","author":"Lee","year":"2010","journal-title":"Clin Exp Allergy"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712519300811?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712519300811?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:43:59Z","timestamp":1758419039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712519300811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0025712519300811"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2019.08.005","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Approach to Patients with Eosinophilia","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2019.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}